By Jeremy Davies2001-02-01T00:00:00
As the roll-call of NICE-approved drugs gets longer, health authorities are under increasing pressure to juggle budgets. Jeremy Davies reports
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud